Drug intelligence / Profile preview

Xiaoer Rekuqing

Development stage: Unknown
Lead developer: Jilin Jian Yisheng Pharmaceutical
Administration: Oral

Overview

Xiaoer Rekuqing is a traditional Chinese medicine (TCM) developed and manufactured by Jilin Jian Yisheng. It is primarily indicated for the treatment of pediatric fever and cough, particularly those associated with "lung heat" (fei re) in traditional Chinese medical theory. The product is formulated to clear heat, detoxify the body, and resolve phlegm to alleviate respiratory symptoms. It is a marketed product in China, typically available in granule form for oral administration.

Brand names: Xiaoer Rekuqing小儿热咳清
Other names: Xiaoer Rekuqing Keli小儿热咳清颗粒

Beyond the preview

Go deeper on Xiaoer Rekuqing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoer Rekuqing.

Explore the full profile